InnoCare Pharma Ltd.(HK:9969)
HK$12.05-0.07 (-0.41%)
HK:9969
InnoCare Pharma Ltd. financials statements
HK$12.05
At close:-0.07 (-0.41%)
Want to see HK:9969 full AI Analyst Report?
InnoCare Pharma Ltd. (9969) Financial Statements
3 Followers
InnoCare Pharma Ltd. Financial Overview
InnoCare Pharma Ltd.'s market cap is currently ¥18.01B. The company's EPS TTM is ¥0.77; its P/E ratio is 12.84; InnoCare Pharma Ltd. is estimated to report earnings on April 1, 2027, and the estimated EPS forecast is ¥0.29. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 2.30B | ¥ 1.01B | ¥ 738.54M | ¥ 625.40M | ¥ 1.04B |
| Gross Profit | ¥ 2.01B | ¥ 871.01M | ¥ 610.10M | ¥ 482.01M | ¥ 977.37M |
| Operating Income | ¥ 440.59M | ¥ -525.78M | ¥ -651.15M | ¥ -770.40M | ¥ -193.87M |
| EBITDA | ¥ 555.89M | ¥ -442.92M | ¥ -516.55M | ¥ -808.28M | ¥ 16.23M |
| Net Income | ¥ 625.84M | ¥ -440.63M | ¥ -631.26M | ¥ -886.59M | ¥ -64.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 7.34B | ¥ 6.22B | ¥ 8.22B | ¥ 9.01B | ¥ 6.25B |
| Total Assets | ¥ 10.83B | ¥ 9.41B | ¥ 9.92B | ¥ 10.32B | ¥ 7.40B |
| Total Debt | ¥ 1.61B | ¥ 1.27B | ¥ 1.35B | ¥ 1.54B | ¥ 1.27B |
| Net Debt | ¥ -5.46B | ¥ -4.95B | ¥ -6.88B | ¥ -7.16B | ¥ -4.66B |
| Total Liabilities | ¥ 3.07B | ¥ 2.66B | ¥ 2.74B | ¥ 2.68B | ¥ 1.74B |
| Stockholders' Equity | ¥ 7.73B | ¥ 6.73B | ¥ 7.15B | ¥ 7.60B | ¥ 5.60B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 130.80M | ¥ -443.78M | ¥ -926.00M | ¥ -935.88M | ¥ -11.00K |
| Operating Cash Flow | ¥ 199.15M | ¥ -365.55M | ¥ -671.34M | ¥ -565.55M | ¥ 167.06M |
| Investing Cash Flow | ¥ -358.03M | ¥ 1.11B | ¥ 666.91M | ¥ -1.73B | ¥ -1.73B |
| Financing Cash Flow | ¥ -32.84M | ¥ -285.60M | ¥ 1.31M | ¥ 3.09B | ¥ 2.54B |
Currency in CNY
